Skip to Content


HER2 and Breast Cancer Recurrence

Cancer Newsline - 12/15/2008

Early-stage Breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein.

Guest(s): Ana M. Gonzalez-Angulo, M.D.

Request an Appointment U.S. News & World Report badge

© 2015 The University of Texas MD Anderson Cancer Center